![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Monday, January 14, 2019 2:45:04 PM
And there are also Blather Breathers that pretend they are independent thinkers, just give the middle a chance.
To make a statement that RGBP could fail or succeed is ludicrous. Implication: there is a 50-50 chance.
Any person that has traded for a minimum of time can look at
1- Balance Sheet (Fundamentals): RGBP is insolvent
2- Price Action (Technicals) RGBP is approaching -100% YOY.
3- Management (Momentum): RGBP's mgm't has been in the game for about a decade and failed at every step. More importantly, this management has failed investors at every step.
4- Patents (Contrarian): OK.... they have patents like so many before, HemaX, right. Of the current crop, Lilly offered them a librarian card (speaks for itself). Also if you have the homework done, you would see there are well over 150 ongoing FDA current trials in this particular field. These trials are being done by big pharma, other pharma with partnerships in place, and small bio-techs with financing in place.
It's almost delusional to think that RGBP can overcome even one the above elements...... oooops, IMO that is not their mission. It is a PR company designed to keep investors sending their $ so Konman Koos can keep that $300K yearly salary....not based on one product or sale; just his pr's
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM